1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide manufacturers
- GSK1940029
-
- $30.00
-
2026-05-11
- CAS:1150701-66-8
- Purity: 99.49%
- Supply Ability: 10g
|
| | 1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide Basic information |
| Product Name: | 1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide | | Synonyms: | 1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide;SCD inhibitor 1;SCD inhibitor 1 GS1940029;1H-1,2,3-Triazole-4-carboxamide, 1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-;SCD inhibitor GSK1940029;Alzheimer's,cancer,SCD inhibitor-1,cardiovascular,diabetes,inhibit,obesity,SCD inhibitor1,metabolic,GSK 1940029,elevated,GSK-1940029,Stearoyl-CoA Desaturase (SCD),GSK1940029,Inhibitor,syndrome,SCD,enzyme;GSK1940029, 10 mM in DMSO;1-(3,4-Dichlorobenzyl)-N-(4-(hydroxymethyl)phenyl)-5-methyl-1H-1,2,3-triazole-4-carboxamide | | CAS: | 1150701-66-8 | | MF: | C18H16Cl2N4O2 | | MW: | 391.25 | | EINECS: | | | Product Categories: | | | Mol File: | 1150701-66-8.mol | ![1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide Structure](CAS/20180703/GIF/1150701-66-8.gif) |
| | 1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMSO : ≥ 32 mg/mL (81.79 mM) | | form | Solid | | color | Light yellow to yellow |
| | 1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide Usage And Synthesis |
| Description | GSK1940029, also known as SCD Inhibitor 1, is a SCD Inhibitor. GSK1940029 is a potential topical treatment of acne, | | Uses | GSK1940029 (SCD inhibitor 1) is a stearoyl-coa desaturase (SCD) inhibitor extracted from patent WO/2009060053 A1, compound example 16. | | References | [1] Anne Marie Jeanne Bouillot, et al. 1, 2, 3-triazole derivatives for use as stearoyl-coa desaturase inhibitors . PCT Int. Appl. (2009), WO 2009060053 A1 20090514. |
| | 1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide Preparation Products And Raw materials |
|